Skip to content
10-Q

Quarterly Report

Kestra Medical Technologies, Ltd. KMTS

0000950170-25-114536

← back to feed
Filed
Sep 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Sep 11, 2025 51.45M sh
Shares Diluted Q1 2025 · Jul 31, 2025 51.3M sh
Shares Diluted Q1 2025 · Jul 31, 2024 19.89M sh
Capex Q1 2025 · Jul 31, 2025 $8.17M
Capex Q1 2025 · Jul 31, 2024 $7.04M
Operating Cash Flow Q1 2025 · Jul 31, 2025 −$26.27M
Operating Cash Flow Q1 2025 · Jul 31, 2024 −$17.5M
Long Term Debt Q1 2025 · Jul 31, 2025 $41.49M
Long Term Debt Q1 2025 · Apr 30, 2025 $41.1M
Cash And Equivalents Q1 2025 · Jul 31, 2025 $201.21M
Cash And Equivalents Q1 2025 · Apr 30, 2025 $237.6M
Cash And Equivalents Q1 2025 · Jul 31, 2024 $99.97M
Stockholders Equity Q1 2025 · Jul 31, 2025 $184.16M
Stockholders Equity Q1 2025 · Apr 30, 2025 $205.41M
Stockholders Equity Q1 2025 · Jul 31, 2024 −$216.47M
Stockholders Equity Q1 2025 · Apr 30, 2024 −$209.38M
Current Liabilities Q1 2025 · Jul 31, 2025 $32.26M
Current Liabilities Q1 2025 · Apr 30, 2025 $37.98M
Total Liabilities Q1 2025 · Jul 31, 2025 $82.14M
Total Liabilities Q1 2025 · Apr 30, 2025 $90.34M
Current Assets Q1 2025 · Jul 31, 2025 $220.69M
Current Assets Q1 2025 · Apr 30, 2025 $255.33M
Total Assets Q1 2025 · Jul 31, 2025 $266.3M
Total Assets Q1 2025 · Apr 30, 2025 $295.74M
Eps Diluted Q1 2025 · Jul 31, 2025 −$0.50
Eps Diluted Q1 2025 · Jul 31, 2024 −$1.12
Eps Basic Q1 2025 · Jul 31, 2025 −$0.50
Eps Basic Q1 2025 · Jul 31, 2024 −$1.12
Sga Expense Q1 2025 · Jul 31, 2025 $33.73M
Sga Expense Q1 2025 · Jul 31, 2024 $19.23M
Rd Expense Q1 2025 · Jul 31, 2025 $4M
Rd Expense Q1 2025 · Jul 31, 2024 $3.4M
Net Income Q1 2025 · Jul 31, 2025 −$25.83M
Net Income Q1 2025 · Jul 31, 2024 −$19.88M
Operating Income Q1 2025 · Jul 31, 2025 −$28.88M
Operating Income Q1 2025 · Jul 31, 2024 −$18.43M
Gross Profit Q1 2025 · Jul 31, 2025 $8.85M
Gross Profit Q1 2025 · Jul 31, 2024 $4.2M
Cost Of Revenue Q1 2025 · Jul 31, 2025 $10.52M
Cost Of Revenue Q1 2025 · Jul 31, 2024 $8.58M
Revenue Q1 2025 · Jul 31, 2025 $19.37M
Revenue Q1 2025 · Jul 31, 2024 $12.78M